CRIS Q4 2019 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+19.3% YoY

Gross Profit

$3M95.1% margin

Operating Income

-$7M-223.1% margin

Net Income

-$9M-261.9% margin

EPS (Diluted)

$-5.18

QoQ Revenue Growth

+15.1%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$692,000

Balance Sheet

Total Assets

$35M

Total Liabilities

$69M

Stockholders' Equity

-$34M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+19.3%
Gross Profit	$3M	$3M	+19.8%
Operating Income	-$7M	-$5M	-42.5%
Net Income	-$9M	-$6M	-44.9%